Relationship between COVID-19 infection and ABO and Rh blood group systems
Öz
Purpose: The aim of this study was to determine whether there is a relationship between COVID-19 infection and ABO and Rh blood groups.
Materials and Methods: 1360 patients with positive SARS-CoV-2 RNA test between April 2020 and March 2022 and 80219 healthy controls whose blood groups were determined before March 2020 were included in this study. Patients were classified according to disease severity as mild, moderate, severe and critical.
Results: Patient and control groups were matched in terms of age and gender using case-control matched method. 1360 patients and 1161 controls were included in the analysis. Of the patients, 42.1% (n=572) had mild, 41.5% (n=564) moderate, 13.8% (n=187) severe and 2.7% (n=37) critical course of infection. It was observed that patients with blood group A were 1.33 times more at risk (OR: 1.33, 95%Cl: 1.12-1.56) for the development of COVID-19 infection compared to patients with other blood groups. No relationship was found between ABO and Rh blood groups and severe-critical COVID-19 disease, need for intensive care and mortality. However, when patients are divided into two groups as mild and non-mild (moderate, severe, critical); the frequency of having O and B blood groups was found to be significantly higher in non-mild cases than in mild cases ( (53.3% and 46.7%), (64.5% and 35.5%, respectively).
Conclusion: In our study, while A blood group was found to be at risk for the development of COVID-19 infection, no relationship was found between Rh blood groups and susceptibility to the disease. In addition, the rate of O and B blood groups was found to be higher in patients who did not have mild disease.
Anahtar Kelimeler
ABO blood group, Rh blood group, COVID-19, ABO blood group, Rh blood group
Kaynakça
- REFERANSLAR 1. World Health Organization (WHO). Last accessed date: 2022 May 6. Available from: https://covid19.who.int/
- 2. Torun A, Damar Çakırca T, Çakırca G, Portakal RD. The value of C-reactive protein/albumin, fibrinogen/albumin, and neutrophil/lymphocyte ratios in predicting the severity of CoVID-19. Revista da Associação Médica Brasileira. 2021;67, 431-6.
- 3. Özger HS, Aysert Yıldız P, Tombul N, Yıldız M, Yıldız Y, Büyükkörük M et al. Relationship Between COVID-19 Clinical Severity and Serum 25(OH)D Levels. Mediterr J Infect Microb Antimicrob. 2021;10:28.
- 4. Çakırca G, Damar Çakırca T, Üstünel M, Torun A, Koyuncu İ. Thiol level and total oxidant/antioxidant status in patients with COVID-19 infection. Ir J Med Sci. 2021; 1:1–6.
- 5. Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020;127:104370.
- 6. Chen Y, Chen G, Chui CH, Lau FY, Chan PKS, Ng MHL et al. ABO blood group and susceptibility to severe acute respiratory syndrome. JAMA. 2005; 293:1450 –1.
- 7. Göker H, Aladağ Karakulak E, Demiroğlu H, Ayaz Ceylan ÇM, Büyükaşik Y, Inkaya AÇ et al. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome. Turk J Med Sci. 2020; 50:679-83.
- 8. Kabrah SM, Kabrah AM, Flemban AF, Abuzerr S. Systematic review and meta-analysis of the susceptibility of ABO blood group to COVID-19 infection. Transfus Apher Sci. 2021;60:103169.
- 9. Golinelli D, Boetto E, Maietti E, Fantini MP. The association between ABO blood group and SARS-CoV-2 infection: A meta-analysis. PLoS One. 2020; 18;15(9):e0239508
- 10. Gutiérrez-Valencia M, Leache L, Librero J, Jericó C, Enguita Germán M, García-Erce JA. ABO blood group and risk of COVID-19 infection and complications: A systematic review and meta-analysis. Transfusion. 2022;62:493-505.
